From Result to Follow-up

#Return to the question and the context

A result should be understood alongside the reason for testing and the available clinical information. MedlinePlus describes the role of symptoms, examination findings, personal history and family history. A positive result may need further information to establish a diagnosis; a result within a reference range is not a guarantee of good health.

Units and the report’s reference information matter too. Laboratories can use different methods and ranges, so a number should not be matched to a range found elsewhere. This is a reading principle, not an interpretation of anyone’s report or an instruction to obtain another test. The clinical team determines what the finding means in its context.

Evidence: MedlinePlus: understanding lab results

#Distinguish receipt, review and action

A result being uploaded or opened shows only part of the work. The 2025 SAFER guide recommends monitoring both clinician acknowledgment and follow-up. AHRQ’s office testing toolkit examines documentation of the result, patient notification, the follow-up plan and whether the plan was acted on.

These stages should not be collapsed into a single completed status when assessing a process. A clinician may decide that no further action is needed; a recorded clinical decision is different from an unexplained absence of follow-up. This page does not define what action is appropriate for any result, or how quickly it should happen. Local clinical policy and the responsible team govern those decisions.

Evidence: ASTP/ONC: 2025 SAFER result reporting and follow-up / AHRQ: office testing process toolkit

#Keep ownership clear when care moves

Results can remain pending when a person leaves hospital or changes teams. AHRQ discharge guidance records which tests are pending, when results are expected, who will follow them up and how the patient will be informed. SAFER asks for responsibility to be unambiguous and for a transfer to another clinician to be accepted, rather than inferred from a copied message.

Coverage during absence and communication of amended reports are also part of the process. SAFER recommends that clinically significant changes reach the clinicians responsible for follow-up, including after a transition. These safety principles support continuity; they are not a claim that Mynd handles records, monitors results or provides clinical care.

Evidence: AHRQ: results pending at discharge / ASTP/ONC: 2025 SAFER result reporting and follow-up

#Make the next step understandable and checkable

A follow-up conversation should distinguish the finding from its interpretation and explain whether there is an agreed next step. AHRQ’s toolkit includes contact preferences and checking patient understanding. SAFER recommends recording communication, whether follow-up is needed, when it should occur and other steps recommended by the clinical team.

A patient being able to see a result is not proof that the plan was explained or completed. The safety process needs a way to identify unfinished work and review communication failures. This is general health-science education, not a clinical pathway, urgency rule or instruction to change testing or treatment. For a particular report, its meaning and follow-up plan belong with the qualified team responsible for that person’s care.

Evidence: AHRQ: office testing process toolkit / ASTP/ONC: 2025 SAFER result reporting and follow-up / MedlinePlus: understanding lab results

Source note

The sections above were checked against the linked sources. No clinical review has been performed. This is general research education, not a clinical guideline.